JP2020524689A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524689A5 JP2020524689A5 JP2019570806A JP2019570806A JP2020524689A5 JP 2020524689 A5 JP2020524689 A5 JP 2020524689A5 JP 2019570806 A JP2019570806 A JP 2019570806A JP 2019570806 A JP2019570806 A JP 2019570806A JP 2020524689 A5 JP2020524689 A5 JP 2020524689A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- disease
- plasminogen
- composition according
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762523901P | 2017-06-23 | 2017-06-23 | |
| US62/523,901 | 2017-06-23 | ||
| PCT/IB2018/000655 WO2018234861A1 (en) | 2017-06-23 | 2018-06-22 | Plasminogen treatment of conditions associated with pai-1 overexpression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020524689A JP2020524689A (ja) | 2020-08-20 |
| JP2020524689A5 true JP2020524689A5 (https=) | 2021-07-29 |
Family
ID=64737041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019570806A Pending JP2020524689A (ja) | 2017-06-23 | 2018-06-22 | Ｐａｉ−１過剰発現に関連する状態のプラスミノーゲン処置 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US11826404B2 (https=) |
| EP (1) | EP3641888B1 (https=) |
| JP (1) | JP2020524689A (https=) |
| KR (1) | KR20200019217A (https=) |
| CN (1) | CN110831668B (https=) |
| AU (1) | AU2018287316B2 (https=) |
| BR (1) | BR112019027229A2 (https=) |
| CA (1) | CA3068153A1 (https=) |
| CL (1) | CL2019003789A1 (https=) |
| DK (1) | DK3641888T3 (https=) |
| ES (1) | ES2965937T3 (https=) |
| FI (1) | FI3641888T3 (https=) |
| IL (1) | IL271470B2 (https=) |
| MX (1) | MX2019015741A (https=) |
| MY (1) | MY203136A (https=) |
| NZ (1) | NZ760921A (https=) |
| RU (1) | RU2020100080A (https=) |
| SG (1) | SG11201912813SA (https=) |
| TW (1) | TWI868051B (https=) |
| WO (1) | WO2018234861A1 (https=) |
| ZA (1) | ZA202000280B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018107686A1 (zh) | 2016-12-15 | 2018-06-21 | 深圳瑞健生命科学研究院有限公司 | 一种治疗动脉粥样硬化及其并发症的方法 |
| JP7168990B2 (ja) | 2016-12-15 | 2022-11-10 | タレンゲン インターナショナル リミテッド | 肥満症を予防および治療するための方法および薬物 |
| TWI677348B (zh) | 2016-12-15 | 2019-11-21 | 大陸商深圳瑞健生命科學研究院有限公司 | 一種改善心臟病變的方法 |
| EP4094775A4 (en) * | 2020-02-06 | 2023-04-19 | Talengen International Limited | METHODS AND MEDICATIONS FOR THE PREVENTION AND TREATMENT OF MULTIPLE SCLEROSIS |
| US20230173039A1 (en) * | 2020-03-24 | 2023-06-08 | Talengen International Limited | Method and drug for treating alzheimer disease |
| EP4122489A4 (en) * | 2020-03-24 | 2023-04-12 | Talengen International Limited | METHODS AND MEDICATIONS FOR PROMOTING THE BREAKDOWN OF MISFOLDED PROTEIN AND AGGREGATE THEREOF |
| CN115697386A (zh) * | 2020-03-24 | 2023-02-03 | 泰伦基国际有限公司 | 一种治疗帕金森病的方法和药物 |
| CN112174979B (zh) * | 2020-10-27 | 2021-09-07 | 黑龙江中医药大学 | 一种治疗多囊卵巢综合征的药物及其制备方法 |
| WO2026006092A1 (en) * | 2024-06-24 | 2026-01-02 | The Cleveland Clinic Foundation | Enzyme encapsulated nanoparticles |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5520912A (en) * | 1993-07-02 | 1996-05-28 | Immuno Aktiengesellschaft | Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen |
| US6677473B1 (en) * | 1999-11-19 | 2004-01-13 | Corvas International Inc | Plasminogen activator inhibitor antagonists |
| AU3173301A (en) * | 2000-02-11 | 2001-08-20 | European Molecular Biology Laboratory | Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity |
| GB0509438D0 (en) | 2005-05-09 | 2005-06-15 | Prometic Biosciences Ltd | Affinity adsorbets for fibrinogen |
| US8318661B2 (en) * | 2006-08-28 | 2012-11-27 | Omnio Healer Ab | Candidates against infection |
| ES2453496T3 (es) | 2006-08-28 | 2014-04-08 | Omnio Healer Ab | Diana farmacológica novedosa de prevención y tratamiento de enfermedad periodontal, mejora de la cicatrización de heridas periodontales y promoción de la salud oral |
| HK1221725A1 (zh) * | 2013-08-13 | 2017-06-09 | Sanofi | 纤溶酶原激活剂抑制剂-1(pai-1)的抗体及其用途 |
| TWI801331B (zh) * | 2015-11-03 | 2023-05-11 | 美商波麥堤克生物治療股份有限公司 | 纖維蛋白溶酶原缺乏症之纖維蛋白溶酶原替代療法 |
| TW201722464A (zh) | 2015-11-10 | 2017-07-01 | 波麥堤克生化科學有限公司 | 用於傷口癒合之纖維蛋白溶酶原給藥方案 |
| JP7242057B2 (ja) | 2016-12-15 | 2023-03-20 | タレンゲン インターナショナル リミテッド | 薬物性腎損傷を予防及び治療するための方法 |
| JP7213552B2 (ja) * | 2016-12-15 | 2023-01-27 | タレンゲン インターナショナル リミテッド | 肝の繊維化を予防及び治療するための方法 |
| JP7168990B2 (ja) * | 2016-12-15 | 2022-11-10 | タレンゲン インターナショナル リミテッド | 肥満症を予防および治療するための方法および薬物 |
-
2018
- 2018-06-15 TW TW107120839A patent/TWI868051B/zh active
- 2018-06-22 DK DK18821458.9T patent/DK3641888T3/da active
- 2018-06-22 BR BR112019027229-1A patent/BR112019027229A2/pt not_active Application Discontinuation
- 2018-06-22 MX MX2019015741A patent/MX2019015741A/es unknown
- 2018-06-22 CN CN201880041573.5A patent/CN110831668B/zh active Active
- 2018-06-22 SG SG11201912813SA patent/SG11201912813SA/en unknown
- 2018-06-22 RU RU2020100080A patent/RU2020100080A/ru unknown
- 2018-06-22 MY MYPI2019007619A patent/MY203136A/en unknown
- 2018-06-22 ES ES18821458T patent/ES2965937T3/es active Active
- 2018-06-22 CA CA3068153A patent/CA3068153A1/en active Pending
- 2018-06-22 KR KR1020207001617A patent/KR20200019217A/ko not_active Ceased
- 2018-06-22 NZ NZ760921A patent/NZ760921A/en unknown
- 2018-06-22 IL IL271470A patent/IL271470B2/en unknown
- 2018-06-22 JP JP2019570806A patent/JP2020524689A/ja active Pending
- 2018-06-22 US US16/625,335 patent/US11826404B2/en active Active
- 2018-06-22 WO PCT/IB2018/000655 patent/WO2018234861A1/en not_active Ceased
- 2018-06-22 AU AU2018287316A patent/AU2018287316B2/en active Active
- 2018-06-22 EP EP18821458.9A patent/EP3641888B1/en active Active
- 2018-06-22 FI FIEP18821458.9T patent/FI3641888T3/fi active
-
2019
- 2019-12-20 CL CL2019003789A patent/CL2019003789A1/es unknown
-
2020
- 2020-01-15 ZA ZA2020/00280A patent/ZA202000280B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020524689A5 (https=) | ||
| BR112015009504A2 (pt) | inibidores de rock | |
| JP2013516482A5 (https=) | ||
| JP2011225596A5 (https=) | ||
| JP2013520405A5 (https=) | ||
| RU2020100080A (ru) | Лечение состояний, связанных с сверхэкспрессией pai-1, с помощью плазминогена | |
| JP2014505733A5 (https=) | ||
| JP2015512406A5 (https=) | ||
| JP2016511267A5 (https=) | ||
| JP2015528471A5 (https=) | ||
| JP2017506624A5 (https=) | ||
| JP2011528333A5 (https=) | ||
| CN102325532A (zh) | 用于减轻肺部炎症的左氧氟沙星吸入剂 | |
| JP2017105861A5 (https=) | ||
| MD4369B1 (ro) | Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei | |
| JP2017105859A5 (https=) | ||
| JP2014139255A5 (https=) | ||
| JP2020504129A (ja) | 非アルコール性脂肪性肝炎（ｎａｓｈ）および肝線維症のための併用療法 | |
| JP2015502389A5 (https=) | ||
| RU2017124487A (ru) | НОВЫЙ ПЕПТИД-ИНГИБИТОР PI3Kγ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ОРГАНОВ ДЫХАНИЯ | |
| JP2014508758A5 (https=) | ||
| CA2519679A1 (en) | Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases | |
| JP2015522077A5 (https=) | ||
| RU2014112324A (ru) | Применение органического соединения для лечения синдрома нунан | |
| US11571455B2 (en) | Methods and compositions for treating alcoholic liver disease |